Source:http://linkedlifedata.com/resource/pubmed/id/15515143
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2005-3-7
|
pubmed:abstractText |
Glycogen storage disease II (GSD-II) is an autosomal recessive lysosomal storage disease, due to acid-alpha-glucosidase (GAA) deficiency. The disease is characterized by massive glycogen accumulation in the cardiac and skeletal muscles. There is early onset (infantile, also known as Pompe disease) as well as late onset (juvenile and adult) forms of GSD-II. Few studies have been published to date that have explored the consequences of delivering a potential therapy to either late onset GSD-II subjects, and/or early onset patients with long-established muscle pathology. One recent report utilizing GAA-KO mice transgenically expressing human GAA (hGAA) suggested that long-established disease in both cardiac and skeletal muscle is likely to prove resistant to therapies. To investigate the potential for disease reversibility in old GSD-II mice, we studied their responsiveness to exogenous hGAA exposure via a gene therapy approach that we have previously shown to be efficacious in young GAA-KO mice.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1099-498X
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright (c) 2004 John Wiley & Sons, Ltd.
|
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
171-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15515143-Adenoviridae,
pubmed-meshheading:15515143-Age Factors,
pubmed-meshheading:15515143-Animals,
pubmed-meshheading:15515143-Blotting, Western,
pubmed-meshheading:15515143-Gene Therapy,
pubmed-meshheading:15515143-Genetic Vectors,
pubmed-meshheading:15515143-Glucan 1,4-alpha-Glucosidase,
pubmed-meshheading:15515143-Glycogen,
pubmed-meshheading:15515143-Glycogen Storage Disease Type II,
pubmed-meshheading:15515143-Histological Techniques,
pubmed-meshheading:15515143-Mice,
pubmed-meshheading:15515143-Mice, Transgenic,
pubmed-meshheading:15515143-Muscles,
pubmed-meshheading:15515143-Time Factors,
pubmed-meshheading:15515143-alpha-Glucosidases
|
pubmed:year |
2005
|
pubmed:articleTitle |
Glycogen storage in multiple muscles of old GSD-II mice can be rapidly cleared after a single intravenous injection with a modified adenoviral vector expressing hGAA.
|
pubmed:affiliation |
Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|